CME Group (CME) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 May, 2026Executive summary
Adjourned annual meeting for Class B Proposals and director elections will be held virtually on June 9, 2026, following failure to achieve a quorum at the original meeting.
Proxies previously submitted remain valid unless revoked or changed before the new voting deadline.
Results of the adjourned meeting will be filed with the SEC within four business days.
Voting matters and shareholder proposals
Shareholders are asked to vote on Items 4, 5, 6, and 7, which relate to Class B Proposals affecting board structure and director election processes.
Approval of proposals will trigger payments of $6,200 per Class B-1 share, $4,100 per Class B-2 share, and $2,000 per Class B-3 share to holders as of the record date.
Voting is available until 10:59 p.m. Central Time on June 8, 2026, with multiple options for participation.
Board of directors and corporate governance
Board recommends transitioning from exchange-specific director requirements to a single class of directors to better align with current market practices.
Proposed changes aim to broaden the pool of qualified nominees and reflect the company's evolution from a member-owned exchange to a global derivatives marketplace.
Board remains committed to strong member representation and expertise in market operations.
Latest events from CME Group
- Director election amendments failed; all nominated directors reelected; no shareholder questions.CME
AGM 20269 Jun 2026 - CFTC's Bitcoin perpetual approval sparks risk warnings amid new product launches and efficiency focus.CME
Piper Sandler Global Exchange and Fintech Conference4 Jun 2026 - Record Q1 2026 with 14% revenue and 20% net income growth, driven by record global trading volumes.CME
Q1 202624 Apr 2026 - Board candidates stress governance, risk oversight, and shareholder advocacy for the 2026 meeting.CME
Proxy filing16 Apr 2026 - Shareholders will vote on director elections, auditor ratification, and key governance amendments.CME
Proxy filing23 Mar 2026 - Shareholders to vote on major governance reforms, executive pay, and director elections.CME
Proxy filing23 Mar 2026 - Proposal to eliminate Class B director election rights, with payments to affected shareholders.CME
Proxy Filing12 Mar 2026 - Shareholders to vote on eliminating Class B director election rights amid record financial performance.CME
Proxy Filing12 Mar 2026 - Global growth, product innovation, and high margins drive record performance and shareholder returns.CME
47th Annual Raymond James Institutional Investor Conference3 Mar 2026